Heterogeneity of wound outcome measures in RCTs of treatments for VLUs: A systematic review

被引:26
作者
Gethin, G. [1 ]
Killeen, F. [1 ]
Devane, D. [1 ,2 ]
机构
[1] Natl Univ Ireland, Sch Nursing & Midwifery, Galway, Ireland
[2] HSE West North West Hosp Grp, Limerick, Ireland
关键词
leg ulcer; randomised controlled trial (RCT); varicose ulcer; venous stasis ulcer; venous ulcer; VENOUS LEG ULCERS; RANDOMIZED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; STRETCH COMPRESSION BANDAGES; DOUBLE-BLIND; TOPICAL TREATMENT; LOCAL-MANAGEMENT; MULTICENTER; EFFICACY; 4-LAYER;
D O I
10.12968/jowc.2015.24.5.211
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: Venous leg ulcers (VLUs) affect up to 4% of the population aged over 65 years. Outcomes of randomised controlled trials (RCTs) in VL Us are important to guide clinical and resource decision making. Our objective was to identify what endpoints and wound bed outcomes were assessed in RCTs in VLUs; how these were assessed and what reference was made to validity and reliability of methods used. Method: A systematic review of all full text RCTs, published in English, from 1998-2013. Results: Our criteria were met by 102 studies. There were 78 different endpoints recorded, the majority (n=34) related to healing and were evaluated at 12 different times points. Size was the most frequently reported outcome measure (n=99), with photographs, tissue type, exudate, odour and pain also recorded. There was poor reporting of methods used to assess outcomes. Visual analogue scales predominated as a method of assessment, but 95% of studies made no reference to the validity or reliability of assessment methods. Conclusion: Future research in VLUs requires standards for measuring outcomes with acceptable inter-rater reliability and validated measures of patient-reported outcomes.
引用
收藏
页码:211 / 226
页数:10
相关论文
共 139 条
[21]  
Cutting KF, 2005, OSTOMY WOUND MANAG, V51, P28
[22]   Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers [J].
da Costa, RM ;
Jesus, FMR ;
Aniceto, C ;
Mendes, M .
WOUND REPAIR AND REGENERATION, 1999, 7 (01) :17-25
[23]   Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers [J].
Dale, JJ ;
Ruckley, CV ;
Harper, DR ;
Gibson, B ;
Nelson, EA ;
Prescott, RJ .
BRITISH MEDICAL JOURNAL, 1999, 319 (7214) :875-878
[24]  
De Sanctis MT, 2002, ANGIOLOGY, V53, pS49
[25]   Topical treatment of venous microangiopathy in patients with venous ulceration with Essaven gel - A placebo-controlled, randomized study [J].
De Sanctis, MT ;
Incandela, L ;
Belcaro, G ;
Cesarone, MR .
ANGIOLOGY, 2001, 52 :S29-S34
[26]   Comparison of costs and healing rates of two forms of compression in treating venous ulcers [J].
DePalma, RG ;
Kowallek, D ;
Spence, RK ;
Caprini, JA ;
Nehler, MR ;
Jensen, J ;
Goldman, MP ;
Bundens, WP .
VASCULAR SURGERY, 1999, 33 (06) :683-690
[27]  
Edwards Helen, 2005, Nurs Stand, V19, P47
[28]   Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial [J].
Falanga, V ;
Fujitani, RM ;
Diaz, C ;
Hunter, G ;
Jorizzo, J ;
Lawrence, PF ;
Lee, BY ;
Menzoian, JO ;
Tretbar, LL ;
Holloway, GA ;
Hoballah, J ;
Seabrook, GR ;
McMillan, DE ;
Wolf, W .
WOUND REPAIR AND REGENERATION, 1999, 7 (04) :208-213
[29]   Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent [J].
Falanga, V ;
Margolis, D ;
Alvarez, O ;
Auletta, M ;
Maggiacomo, F ;
Altman, M ;
Jensen, J ;
Sabolinski, M ;
Hardin-Young, J .
ARCHIVES OF DERMATOLOGY, 1998, 134 (03) :293-300
[30]   The treatment of venous leg ulcers - A new therapeutic use of Iloprost [J].
Ferrara, Filippo ;
Meli, Francesco ;
Raimondi, Francesco ;
Amato, Corrado ;
Bonura, Francesca ;
Mule, Giuseppe ;
Novo, Giuseppina ;
Salvatore, Novo S. .
ANNALS OF SURGERY, 2007, 246 (05) :860-865